Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Artemis Medicare Services's interest expense for the
three
months ended in Jun. 2026 was ₹ -65 Mil.
Its interest expense for the trailing twelve months (TTM) ended in Jun. 2026 was ₹-268 Mil.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's financial strength is.
Artemis Medicare Services Interest Expense Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Interest Expense is the amount reported by a company or individual as an expense for borrowed money.
Interest Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-268 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Artemis Medicare Services (BOM:542919) has a Interest Expense of ₹-268 Mil as of Jun. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Artemis Medicare Services and its competitors.
Is Artemis Medicare Services' Interest Expense too high?
Artemis Medicare Services' current Interest Expense is ₹-268 Mil. Overall, Artemis Medicare Services has a GF Score™ of 87/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Artemis Medicare Services' Interest Expense compare to HCA and THC?
Artemis Medicare Services' Interest Expense of ₹-268 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Healthcare Providers & Services company?
A good Interest Expense depends on the Healthcare Providers & Services industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Artemis Medicare Services and its competitors. Artemis Medicare Services's current Interest Expense is ₹-268 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Artemis Medicare Services stock overvalued right now?
Based on GuruFocus' analysis, Artemis Medicare Services (BOM:542919) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹277.84, compared to a current price of ₹315.05 — trading 13.4% above its estimated fair value. The current Interest Expense is ₹-268 Mil. Artemis Medicare Services' overall GF Score™ is 87/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Artemis Medicare Services (BOM:542919), the current Interest Expense is ₹-268 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Artemis Medicare Services (BOM:542919) Overvalued in 2026?
Based on GuruFocus' analysis, Artemis Medicare Services stock appears to be overvalued.
The current stock price of ₹315.05 is trading 13.4% above its estimated GF Value™ of ₹277.84.
GuruFocus considers Artemis Medicare Services to be Modestly Overvalued.
Key valuation signals for BOM:542919:
Interest Expense: ₹-268 Mil
GF Value™: ₹277.84 vs. price of ₹315.05 (13.4% above fair value)
No single metric tells the full story. See the BOM:542919 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Artemis Medicare Services Ltd is engaged in managing and operating multi-specialty hospitals. The hospital provides treatments for Allergy and Immunology, Blood (Haematology), Bones, Muscles and Joints (Orthopaedics), Brain, Spine and Nervous System, Cancer (Oncology), Circulatory (Vascular), Digestive (Gastroenterology), Endocrine, Diabetes And Metabolism, Dermatology, Heart (Cardiology), Infectious Diseases, Kidneys (Renal), Lung (Pulmonary), Mouth, Teeth And Face (Oral And Maxillofacial), Obstetrics And Gynecology, Psychiatry, Rheumatology (Arthritis And Joint Disease), Surgery, and Urology. The company derives revenue mainly from Healthcare Services through the operation of multi-specialty Hospitals.
87GF Score
Get the complete analysis for BOM:542919
Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:542919 has been successfully added to your 
